In April 2021, the New York Times revealed that Ursula von der Leyen, the President of the European Commission, was negotiating directly with Albert Bourla, the CEO of Pfizer, through phone calls and text messages[2]. And indeed, the following month, the Commission announced a mega-contract with the alliance of...